REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 72,007$1,822,4970.00%
GROUP ONE TRADING, L.P. 8,777$222,1460.00%
Legal & General Group Plc 77,918$1,972,1040.00%
JANUS HENDERSON GROUP PLC 38,575$975,7620.00%
NATIXIS 6,455$163,3760.00%
LOS ANGELES CAPITAL MANAGEMENT LLC 8,530$215,8940.00%
NEW YORK STATE COMMON RETIREMENT FUND 33,454$8470.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 23,681$599,3660.00%
Janney Montgomery Scott LLC 16,010$4050.00%
DEUTSCHE BANK AG\ 39,842$1,008,4010.00%
CITIGROUP INC 38,708$979,6990.00%
MERCER GLOBAL ADVISORS INC /ADV 9,161$2320.00%
UBS ASSET MANAGEMENT AMERICAS LLC 90,914$2,928,3400.00%
Parallax Volatility Advisers, L.P. 10,085$255,2510.00%
UBS Group AG 130,025$3,290,9320.00%
KEYBANK NATIONAL ASSOCIATION/OH 13,021$329,5620.00%
WOLVERINE TRADING, LLC 27,800$686,6600.00%
WOLVERINE TRADING, LLC 33,100$817,5700.00%
WOLVERINE TRADING, LLC 19,346$477,8460.00%
Point72 Asset Management, L.P. 11,300$286,0030.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.